In the DLB group, we found that higher plasma levels of GFAP and NfL were associated with greater brain atrophy in medial temporal and frontal brain areas as well as with a higher cerebrovascular lesion load (Fazekas). This evidence concerns the gene NEFL and Brain atrophy.